Stock Analysis
Cencora, Inc. (COR) Stock Analysis
Cencora, Inc. (COR) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Cencora, Inc. (COR) currently has an AIQ Score of 55/100, indicating a neutral setup. Value is the strongest factor at 62/100. Quality is the weakest current factor at 42/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
COR at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $321.57 |
| AIQ Score | 55/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Neutral |
| Market Cap | $64.39B |
| P/E Ratio | 19.3 |
| Forward P/E | — |
| EPS | $3.95 |
| Revenue TTM | $84.75B |
| Dividend Yield | 0.00% |
| Beta | 0.57 |
| Volume | 850.94K |
| 52-week range | $244.82-$377.54 |
| RSI 14 | 53.55 |
| 50-Day SMA | $315.13 |
| 200-Day SMA | $321.13 |
| Analyst Price Target | $363.73 |
| Next Earnings | Nov 4, 2026 |
COR
OverviewCOR Stock Analysis Summary
Cencora, Inc. (COR) currently has an AIQ Score of 55/100, indicating a neutral setup. Value is the strongest factor at 62/100. Quality is the weakest current factor at 42/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, COR has AIQ Score of 55/100 with Value base of 62/100 and fading Quality at 42/100. Wait for component alignment before adding exposure.
Value (62/100) leads while Quality (42/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 0.19% stock move · COR classified in Medical - Distribution.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is COR Bullish or Bearish Right Now?
COR currently has a neutral overall setup. Value is the strongest factor at 62/100, while Quality is weakest at 42/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 60/100.
- - Price is +2.04% above its 50-day SMA.
- - Analyst target implies +13.11% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (19 vs 18).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
COR's Technical Analysis Consensus is currently Neutral, with 19 buy, 8 neutral, and 18 sell votes. COR's 14-day RSI is 53.55, which places the stock in a neutral momentum range. COR's beta is 0.57, indicating lower market sensitivity than the broad market.
What Changed in COR?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the COR Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
COR Decision Framework
Public evidence layers, setup checks, and risk context for Cencora, Inc..
Cencora, Inc. (COR) Stock Analysis
Cencora, Inc. has an AIQ Score of 55/100 in a Neutral regime. Value is strongest at 62/100. Beta is 0.57, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | COR is in a Neutral AIQ regime with score 55/100. |
| Signal Conflict | The primary conflict is that value leads at 62/100 while quality lags at 42/100. |
| Factor Evidence | Momentum 60/100 · Value 62/100 · Quality 42/100 · Risk 59/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 62/100.
Momentum is 60/100 and RSI (14) is 53.5.
COR is in a Neutral regime at 55/100.
Risk factor is 59/100 with beta 0.57 and annual volatility 31.54%.
Current conflict: value leads at 62/100 while quality lags at 42/100.
COR Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
COR Fundamentals
COR valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
COR Technical Analysis
COR technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
COR Stock Catalysts
Track COR earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
COR Dividend Analysis
COR dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
COR Financial Data
COR revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
COR Risk Analysis
COR volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
COR Stock News
COR stock news, market tone, recent headlines, and catalyst context.
COR vs Healthcare Services / Managed Care Peers
Current peer cohort: COR · CVS · DGX · DOCS · DVA. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| COR Current stock | 55/100 | 62/100 | 60/100 | 59/100 | 0.3 | 31.54% | Current |
| CVS CVS Health | 51/100 | 70/100 | 55/100 | 53/100 | 0.84 | 30.62% | COR vs CVS |
| DGX Quest Diagnostics | 50/100 | 53/100 | 42/100 | 60/100 | 1.07 | 23.85% | COR vs DGX |
| DOCS Doximity | 59/100 | 46/100 | 55/100 | 56/100 | -1.31 | 63.74% | COR vs DOCS |
| DVA DaVita | 59/100 | 68/100 | 66/100 | 57/100 | 0.83 | 45.08% | COR vs DVA |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts7 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching COR
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for COR
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
COR Stock FAQ
What is COR stock price today?
Cencora, Inc.'s current stock price is $321.57. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is COR bullish or bearish right now?
COR's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is COR's market cap?
COR's market cap is $64.39B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is COR's current P/E ratio?
COR's current P/E ratio is 19.3 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is COR's RSI?
COR's 14-day RSI is 53.55 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is COR above its 50-day and 200-day moving averages?
COR is 2.04% from its 50-day SMA and 0.14% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is COR's next earnings date?
COR's next earnings date is currently listed as Nov 4, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does COR pay a dividend?
COR's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.